EUVIMEDEUVIMED entdecken
Open Access

National Outpatient Sexually Transmitted Infection Testing in Pregnant Patients in the United States

Kelsey A Strey, Hannah C Angeles, Vidal M Mendoza, Kelly R Reveles

Journal of Women's Health · 2024

DOI: 10.1089/jwh.2023.0865 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Women's Health, 2024. Verfasst von Kelsey A Strey und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, The University of Texas at Austin, Austin, Texas, USA. Hauptthemen laut MEDLINE: Sexually Transmitted Diseases, Mass Screening. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Sexually transmitted infections (STIs) continue to increase in the United States and pregnant patients who acquire STIs are at risk for serious complications. This study estimated the utilization of preventative STI testing among pregnant outpatients on a national scale.

Methods

This was a retrospective, cross-sectional study of outpatient visits in the National Ambulatory Medical Care Survey from 2014 to 2016 and 2018 to 2019. All patients reported as pregnant were included to assess STI testing for chlamydia, gonorrhea, hepatitis, and HIV. STI testing was described per 1,000 total visits overall and by subpopulations. Data weights were applied to generate national estimates.

Results

Over 177 million visits were included, of which 87.5 per 1,000 included an STI test. Chlamydia testing was the most common, followed by HIV, gonorrhea, and hepatitis (58.0 vs. 42.3 vs. 41.5 vs. 20.3 per 1,000). STI testing rates varied across subpopulations (72.1-236.6 per 1,000 visits). Patients of Hispanic ethnicity, Black race, age ≤25 years old, and those seen by an obstetrics and gynecology (OB/GYN) provider had the highest rates of STI testing. Independent predictors of STI testing included: Black race (adjusted odds ratio [aOR]: 2.24, 95% confidence interval [95% CI]: 2.23-2.24), first trimester (aOR: 5.15, 95% CI: 5.14-5.16), government and private insurance (aOR: 1.90, 95% CI: 1.89-1.91 and aOR: 1.70, 95% CI: 1.69-1.71), and an OB/GYN provider specialty (aOR: 2.93, 95% CI: 2.93-2.94).

Conclusions

STI testing in United States outpatient physician offices varied by subpopulations and across individual test types. Certain patient attributes, such as race, provider specialty, and payment source, were predictive of testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sexually Transmitted DiseasesMass ScreeningHumansFemalePregnancyUnited StatesCross-Sectional StudiesRetrospective StudiesAdultYoung AdultOutpatientsAdolescentPregnancy Complications, InfectiousHealth Care SurveysAmbulatory Care

Stichwörter der Autor:innen

epidemiologyhealth disparitiespregnancysexually transmitted infection

Autor:innen und Institutionen

  • College of Pharmacy, The University of Texas at Austin, Austin, Texas, USA.
  • Pharmacotherapy Education and Research Center, University of Texas Health San Antonio, San Antonio, Texas, USA.

Zitieren

APA

Strey, K. A., Angeles, H. C., Mendoza, V. M., & Reveles, K. R. (2024). National Outpatient Sexually Transmitted Infection Testing in Pregnant Patients in the United States. Journal of Women's Health. https://doi.org/10.1089/jwh.2023.0865

Vancouver

Strey KA, Angeles HC, Mendoza VM, Reveles KR. National Outpatient Sexually Transmitted Infection Testing in Pregnant Patients in the United States. Journal of Women's Health. 2024. doi:10.1089/jwh.2023.0865

BibTeX
@article{Strey2024,
  author = {Strey, Kelsey A and Angeles, Hannah C and Mendoza, Vidal M and Reveles, Kelly R},
  title = {National Outpatient Sexually Transmitted Infection Testing in Pregnant Patients in the United States},
  journal = {Journal of Women's Health},
  year = {2024},
  doi = {10.1089/jwh.2023.0865}
}
Kostenlos starten →